Evidence map›Paper›PMID 31534435›Full record

ArticleSarcoma

Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy".

Edwin Choy, Karla Ballman, James Chen, Mark A Dickson, Rashmi Chugh, Suzanne George, Scott Okuno, Raphael Pollock, Rajiv M Patel, Antje Hoering and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Sarcoma. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy.Frontiers in cell and developmental biology · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Edwin ChoyMassachusetts General Hospital, Division of Hematology Oncology, 55 Fruit Street, Boston, MA 02114, USA.ORCID https://orcid.org/0000-0001-9896-8084
Karla BallmanWeill Cornell Medicine Healthcare Policy and Research, 402 East 67th Street, LA-225, New York, NY 10065, USA.
James ChenThe Ohio State University Comprehensive Cancer Center, 1800 Cannon Drive, 250 Lincoln Tower, Columbus, OH 43210, USA.
Mark A DicksonMemorial Sloan Kettering Cancer Center and Weill Cornell Medical College, 300 E. 66th Street, New York, NY 10065, USA.
Rashmi ChughUniversity of Michigan Comprehensive Cancer Center, 1500 E. Medical Center Drive, Rm C-407 MIB/SPC 5843, Ann Arbor, MI 48109, USA.ORCID https://orcid.org/0000-0002-4633-6971
Suzanne GeorgeDana-Farber Cancer Institute, Center for Sarcoma and Bone Oncology, 450 Brookline Ave, D-1212, Brookline, MA 02215, USA.
Scott OkunoMayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.ORCID https://orcid.org/0000-0002-1297-6946
Raphael PollockOhio State University Wexner Medical Center, 410 West 10th Avenue, N924 Doan Hall, Columbus, OH 43206, USA.
Rajiv M PatelMichigan Medicine, Department of Pathology, 1301 Catherine Street, SPC 5602, 3261G Medical Science I, Ann Arbor, MI 48109-5602, USA.
Antje HoeringCancer Research and Biostatistics, 1730 Minor Ave, Suite 1900, Seattle, WA 98101, USA.
Shreyaskumar PatelMD Anderson Cancer Center, Sarcoma Medical Oncology, 1400 Holcombe Blvd, Unit 450, Houston, TX 77030, USA.ORCID https://orcid.org/0000-0002-0026-2348

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1155/2018/2068517.].

Identifiers

PMID31534435
PMCPMC6732588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.